Hunan Erkang Pharmaceutical Co., Ltd

Name

Hunan Erkang Pharmaceutical Co., Ltd

Legal name

Hunan Erkang Pharmaceutical Co., Ltd

Website

https://vegecaps.com

Company type

Private

Headcount range

11–50 employees

Short description

Hunan Erkang Pharmaceutical Co., Ltd is a small Changsha, Hunan-based Chinese pharmaceutical company founded in 2010, operating vegecaps.com and focused on vegetable capsule shells for pharmaceutical and nutraceutical oral dosage delivery, with 26 employees.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical manufacturing
• Vegetable capsules
• Empty capsule shells
• Capsule production
• Pharmaceutical excipients

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D

Core offering

Hunan Erkang Pharmaceutical Co., Ltd is a pharmaceutical manufacturer based in Changsha, Hunan, China, founded in 2010. The company's website domain (vegecaps.com) indicates a focus on vegetable-based capsule production, supplying empty capsule shells and related pharmaceutical products. With approximately 26 employees, it operates as a small-scale manufacturer in the pharmaceutical sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Vegetable Capsules

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Natural Capsules: Natural Capsules Limited is an Indian manufacturer of hard gelatin and HPMC capsules. It represents a comparable emerging-market peer pursuing similar pharma and nutraceutical capsule customers.

Broad incumbents

• Catalent: Catalent is a global CDMO that, among many services, offers capsule-related softgel and oral-dose solutions. As a broad incumbent in pharmaceutical dosage forms, it represents the scale benchmark and adjacent competitor for capsule-focused manufacturers.
• Lonza (Capsugel): Lonza owns Capsugel, the world's largest empty-capsule manufacturer offering both gelatin and HPMC (vegetable) capsules. It is the benchmark competitor for any plant-based capsule producer and shares the same end-customers in pharma and nutraceuticals.

Direct peers

• ACG (Associated Capsules Group): ACG is a leading global manufacturer of empty hard capsules including HPMC vegetable capsules, serving pharmaceutical and nutraceutical customers. It is the most direct comparably-sized competitor to a China-based vegetable capsule specialist.
• Suheung: Suheung is a Korean manufacturer of empty hard capsules (gelatin and HPMC) serving pharma and nutraceutical markets across Asia and globally. It is a direct Asia-based peer in vegetable capsule manufacturing.
• Qualicaps: Qualicaps is a Japanese-headquartered manufacturer of empty pharmaceutical capsules including HPMC plant-based options, supplying global pharma and health-product companies. It competes in the same vegetable-capsule category.
• CapsCanada: CapsCanada is a North American manufacturer of empty capsules including HPMC vegetable capsules. It is a smaller, focused competitor that mirrors the niche, specialized positioning a small Chinese capsule maker would need to occupy.
• Shandong Healsee Capsule: Healsee is a Chinese HPMC vegetable capsule producer serving nutraceutical and pharmaceutical customers. It is a direct regional competitor offering similar plant-based capsule products.
• Lefan Capsule: Lefan is a Chinese manufacturer specializing in HPMC vegetable capsules for pharmaceutical and supplement applications. As a domestic Chinese peer, it competes for similar buyers in the same local and export markets.
• Fuji Capsule: Fuji Capsule is a Japanese manufacturer of empty hard capsules including plant-based options. It is a relevant Asia-Pacific peer competing in the same regulated dosage-form segment.

Market position

Customer concentration

• LinkedInlinkedin.com/company/erkangpharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hunan Erkang Pharmaceutical Co., Ltd